| Ident. | Authors (with country if any) | Title |
|---|
| 000001 (2020) |
A. Prasse [Allemagne] ; F. Bonella [Allemagne] ; U. Müller-Ladner [Allemagne] ; T. Witte [Allemagne] ; N. Hunzelmann [Allemagne] ; J. Distler [Allemagne] | [Treatment of systemic sclerosis-associated interstitial lung disease]. |
| 000002 (2020) |
L. Horvath [Allemagne] ; B. Hellmich [Allemagne] | [Treatment of giant cell arteritis and polymyalgia rheumatica]. |
| 000009 (2020) |
C B Wu [République populaire de Chine] ; H Y Zhang [République populaire de Chine] ; S H Shao [République populaire de Chine] ; L W Dou [République populaire de Chine] ; Q Y Zhou [République populaire de Chine] ; Y. Liu [République populaire de Chine] ; W B Gao [République populaire de Chine] ; J H Zhu [République populaire de Chine] | [A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis]. |
| 000011 (2020) |
Binqing Fu ; Xiaoling Xu ; Haiming Wei | Why tocilizumab could be an effective treatment for severe COVID-19? |
| 000022 (2020) |
Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie] | Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome |
| 000023 (2020) |
Yehyun Park [Corée du Sud] ; Jae Hee Cheon [Corée du Sud] | Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents. |
| 000027 (2020) |
Shanshan Deng [États-Unis, République populaire de Chine] ; Michael J. Clowers [États-Unis] ; Walter V. Velasco [États-Unis] ; Marco Ramos-Castaneda [États-Unis] ; Seyed Javad Moghaddam [États-Unis] | Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment |
| 000035 (2020) |
Limin Li [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Mengyuan Xu [République populaire de Chine] ; Hongjuan Yu [République populaire de Chine] ; Chengfang Lv [République populaire de Chine] ; Fenglin Cao [République populaire de Chine] ; Zhenkun Wang [République populaire de Chine] ; Yueyue Fu [République populaire de Chine] ; Mingwen Zhang [République populaire de Chine] ; Hongbin Meng [République populaire de Chine] ; Xiaoqian Zhang [République populaire de Chine] ; Liqing Kang [République populaire de Chine] ; Zhuo Zhang [République populaire de Chine] ; Jinmei Li [République populaire de Chine] ; Jiawei Feng [République populaire de Chine] ; Xin Lian [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Jin Zhou [République populaire de Chine] | Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients |
| 000036 (2020) |
B P Hibler [États-Unis] ; A. Markova [États-Unis] | Treatment of severe cutaneous adverse reaction with tocilizumab. |
| 000037 (2020) |
Huiqiong Zeng ; Baiwei Luo ; Yue Zhang ; Zhongyu Xie ; Zhizhong Ye | Treatment of reactive arthritis with biological agents: a review |
| 000038 (2020) |
Maria C. Cid [Espagne] ; Roberto Ríos-Garcés [Espagne] ; Nekane Terrades-García [Espagne] ; Georgina Espígol-Frigolé [Espagne] | Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies. |
| 000039 (2020) |
Hsien-Fu Chiu [Taïwan] ; Mei-Chin Wen [Taïwan] ; Ming-Ju Wu [Taïwan] ; Cheng-Hsu Chen [Taïwan] ; Tung-Min Yu [Taïwan] ; Ya-Wen Chuang [Taïwan] ; Shih-Ting Huang [Taïwan] ; Shang-Feng Tsai [Taïwan] ; Ying-Chih Lo [Taïwan] ; Hao-Chung Ho [Taïwan] ; Kuo-Hsiung Shu [Taïwan] | Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study |
| 000040 (2020) |
S. Panopoulos [Grèce] ; Chatzidionysiou [Grèce] ; M. G. Tektonidou [Grèce] ; V. K. Bournia [Grèce] ; A. A. Drosos [Grèce] ; Stamatis-Nick C. Liossis [Grèce] ; T. Dimitroulas [Grèce] ; L. Sakkas [Grèce] ; D. Boumpas [Grèce] ; P. V. Voulgari [Grèce] ; D. Daoussis [Grèce] ; K. Thomas [Grèce] ; G. Georgiopoulos [Grèce] ; G. Vosvotekas [Grèce] ; Garyfallos [Grèce] ; P. Sidiropoulos [Grèce] ; G. Bertsias [Grèce] ; D. Vassilopoulos [Grèce] ; P. P. Sfikakis [Grèce] | Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort |
| 000041 (2020) |
Hadir Shakshouk [États-Unis, Égypte] ; Maryam Daneshpazhooh [Iran] ; Dedee F. Murrell [Australie] ; Julia S. Lehman [États-Unis] | Treatment considerations for patients with pemphigus during the COVID-19 pandemic |
| 000042 (2020) |
Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis] | Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof) |
| 000048 (2020) |
Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie] | Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review. |
| 000054 (2020) |
Rongda Li [République populaire de Chine] ; Qi Wan [République populaire de Chine] ; Pan Chen [République populaire de Chine] ; Shufen Mao [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Xiaoxin Li [République populaire de Chine] ; Yi Yang [République populaire de Chine] ; Li Dong [République populaire de Chine] | Tocilizumab treatment in Felty's syndrome. |
| 000055 (2020) |
Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine] | Tocilizumab treatment in COVID-19: A single center experience. |
| 000056 (2020) |
Martin Krusche [Allemagne] ; Nikolas Ruffer [Allemagne] ; Udo Schneider [Allemagne] ; Marco Meyer [Allemagne] ; Gerd Burmester [Allemagne] ; Ina Kötter [Allemagne] | Tocilizumab treatment for polyarteritis nodosa. |
| 000057 (2020) |
Lili Pan [République populaire de Chine] ; Juan Du [République populaire de Chine] ; Jiayi Liu [République populaire de Chine] ; Hua Liao [République populaire de Chine] ; Xiaoli Liu [République populaire de Chine] ; Xi Guo [République populaire de Chine] ; Jing Liang [République populaire de Chine] ; Hongya Han [République populaire de Chine] ; Lixia Yang [République populaire de Chine] ; Yujie Zhou [République populaire de Chine] | Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis. |
| 000071 (2020) |
Roos A W. Wennink [Pays-Bas] ; Viera Kalinina Ayuso [Pays-Bas] ; Lieuwe A. De Vries [Pays-Bas] ; Sebastiaan J. Vastert [Pays-Bas] ; Joke H. De Boer [Pays-Bas] | Tocilizumab as an Effective Treatment Option in Children with Refractory Intermediate and Panuveitis. |
| 000078 (2020) |
Phulen Sarma ; Manisha Prajapat ; Pramod Avti ; Hardeep Kaur ; Subodh Kumar ; Bikash Medhi | Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach |
| 000079 (2020) |
Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie] | Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review |
| 000081 (2020) |
Francisco Vílchez-Oya [Espagne] ; Julia María Sánchez-Schmidt [Espagne] ; Anna Agustí [Espagne] ; Ana Pros [Espagne] | The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review. |
| 000083 (2020) |
Wen Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Fengchun Zhang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuan Zhang [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine] | The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China |
| 000102 (2020) |
Xiaoyan He [République populaire de Chine] ; Qingyan Ma [République populaire de Chine] ; Yajuan Fan [République populaire de Chine] ; Binbin Zhao [République populaire de Chine] ; Wei Wang [République populaire de Chine] ; Feng Zhu [République populaire de Chine] ; Xiancang Ma [République populaire de Chine] ; Lina Zhou [République populaire de Chine] | The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia |
| 000112 (2020) |
Sam E. Mansour [États-Unis] ; David J. Browning [États-Unis] ; Keye Wong [États-Unis] ; Harry W. Flynn Jr [États-Unis] ; Abdhish R. Bhavsar [États-Unis] | The Evolving Treatment of Diabetic Retinopathy |
| 000121 (2020) |
Mattia Rosso [États-Unis] ; Shrishti Saxena [États-Unis] ; Tanuja Chitnis [États-Unis] | Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options. |
| 000133 (2020) |
Saeed K. Alzghari [États-Unis] ; Valerie S. Acu A [États-Unis] | Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review. |
| 000135 (2020) |
Yixin Ally Wang [États-Unis] ; Misha Rosenbach [États-Unis] | Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case |
| 000136 (2020) |
Gehan Elolemy [Koweït] ; Abdulrahman Al Rashidi [Koweït] ; Ahmed Dehrab [Koweït] ; Ammar Almathkouri [Koweït] ; Alex Varghese [Koweït] ; Mustafa Chikhly [Koweït] ; Fatema Alkhawaja [Koweït] | Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report. |
| 000137 (2020) |
Gui Wang ; Xiao-Rong Jin ; De-Xun Jiang | Successful treatment of adult-onset still disease caused by pulmonary infection-associated hemophagocytic lymphohistiocytosis: A case report |
| 000138 (2020) |
Hao Zhang ; Yongxian Hu | Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib |
| 000140 (2020) |
Yusho Ishii [Japon] ; Hiroshi Fujii [Japon] ; Koichiro Sugimura [Japon] ; Tsuyoshi Shirai [Japon] ; Yosuke Hoshi [Japon] ; Yoko Fujita [Japon] ; Yuko Shirota [Japon] ; Tomonori Ishii [Japon] ; Hiroaki Shimokawa [Japon] ; Hideo Harigae [Japon] | Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody |
| 000141 (2020) |
Adam Amlani [Canada] ; Claire Barber [Canada] ; Aurore Fifi-Mah [Canada] ; Jose Monzon [Canada] | Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature. |
| 000142 (2020) |
Huub J. Poelman [Pays-Bas] ; Paul L A. Van Daele [Pays-Bas] ; A. Rothova [Pays-Bas] | Successful Tocilizumab Treatment for Scleritis. |
| 000151 (2020) |
Joanna Wai Yee Leong [Singapour] ; Peter P. Cheung [Singapour] ; Sajeewani Dissanayake [Singapour] ; Warren Weng Seng Fong [Singapour] ; Keng Hong Leong [Singapour] ; Ying Ying Leung [Singapour] ; Anita Yee Nah Lim [Singapour] ; Nai Lee Lui [Singapour] ; Mona Manghani [Singapour] ; Amelia Santosa [Singapour] ; Melonie Kannamma Sriranganathan [Singapour] ; Ernest Suresh [Singapour] ; Teck Choon Tan [Singapour] ; Gim Gee Teng [Singapour] ; Manjari Lahiri [Singapour] | Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis. |
| 000159 (2020) |
Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis] | Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes |
| 000168 (2020) |
Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon] | Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan |
| 000172 (2020) |
Di Mauro Gabriella ; Scavone Cristina ; Rafaniello Concetta ; Rossi Francesco ; Capuano Annalisa | SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment |
| 000192 (2020) |
Igor Kos [Allemagne] ; Stephan Stilgenbauer [Allemagne] ; Moritz Bewarder [Allemagne] | Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature. |
| 000202 (2020) |
Giorgia Bucciol [Belgique] ; Isabelle Meyts [Belgique] | Recent advances in primary immunodeficiency: from molecular diagnosis to treatment |
| 000203 (2020) |
Jae-A Park [Corée du Sud] ; Min-Young Lee [Corée du Sud] ; Jin Hyun Nam [États-Unis] ; Ju-Young Shin [Corée du Sud] ; Robert Wood [Royaume-Uni] ; Tim Holbrook [Royaume-Uni] ; Sun-Hong Kwon [Corée du Sud] | Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea. |
| 000205 (2020) |
Karin Luttropp [Suède] ; Johan Dalén [Suède] ; Axel Svedbom [Suède] ; Mary Dozier [États-Unis] ; Christopher M. Black [États-Unis] ; Amy Puenpatom [États-Unis] | Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review |
| 000207 (2020) |
Shengyu Zhang ; Lei Li ; Aizong Shen ; Yongwu Chen ; Zhigang Qi | Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia |
| 000233 (2020) |
Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie] | Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? |
| 000236 (2020) |
Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink ; Stein Bergan [Norvège] ; Dirk Jan A. R. Moes ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France] | Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions |
| 000245 (2020) |
Ana Luisa Oliveira [Portugal] ; Carina Ruano [Portugal] ; Nuno Riso [Portugal] ; José Cepeda Ribeiro [Portugal] ; Maria Francisca Moraes-Fontes [Portugal] | Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia. |
| 000248 (2020) |
María Alejandra Marín-Noriega [Colombie] ; Juliana Mu Oz-Ortiz [Colombie] ; Catalina Mosquera [Colombie] ; Alejandra De-La-Torre [Colombie] | Ophthalmological treatment of early-onset sarcoidosis/Blau syndrome in a Colombian child: A case report |
| 000250 (2020) |
Maurizio Benucci [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Luca Quartuccio [Italie] | Old and new antirheumatic drugs for the treatment of COVID-19 |
| 000257 (2020) |
Stefanie Glaubitz ; Rachel Zeng ; Jens Schmidt | New insights into the treatment of myositis |
